
|Articles|June 22, 2017
Applying Biologic Advances in Multiple Myeloma to Clinical Practice
Author(s)Gareth J. Morgan, MD
In this video, Gareth J. Morgan, MD, discusses the new biologic advances in multiple myeloma and how they are currently being applied to clinical practice.
Advertisement
Gareth J. Morgan, MD, of the University of Arkansas for Medical Sciences in Little Rock, Arkansas, discusses the biologic advances in multiple myeloma, and how identified mutations and pathways can offer opportunities for patients to receive targeted therapies.
Dr. Morgan gave a presentation during an education session at the 2017 ASCO Meeting entitled, "Are We Integrating Biologic Advances in Multiple Myeloma Into Clinical Practice"?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Prophylaxis and Practical Implementation of the COPERNICUS Approach
2
New ASCO Guideline Offers Recommendations for Smoldering Multiple Myeloma
3
Neoadjuvant Pembrolizumab Yields High pCR Rate in Desmoplastic Melanoma
4
Fecal Microbiota Transplantation Shows Feasibility in Metastatic RCC
5



































